FY043 CW1 SWOT Analysis Assignment Sample
Here’s the best sample of FY043 CW1 SWOT Analysis Assignment, written by the expert.
Strength
The strength of GSK includes their strong R&D portfolio that assists the organisation in introducing new pharmaceutical products helping the company fortify its market situation (Gsk, 2021). The strong distribution system of GSK helps the organisation in making their products available in the market that assist them in building a positive relationship with the customers. GSK strong global presence in over 100 countries across the globe has helped the firm in achieving competitive advantages over its competitors (Gsk, 2021). Moreover, the strong financial capital of GSK benefits them in investing in technology and the growth of the organisation also strengthen their market position in the competitive environment.
Weakness
The weakness that is being faced by GSK includes suffering from fraud allegations that affect their brand image. GSK in some countries has illegally endorsed medicine drugs and false pricing charges (Drugwatch, 2021). The organisation has also been accused of failing to report safety data. Another challenge that is being faced by GSK includes their core products being exposed to general rivalry and reaching maturity as a result of which competition grows and decreases the revenue earning capability of the organisation. Maturi of their drugs is also making it challenging for them in providing better medicines to the people decreases their trust towards the organisation leading to low growth of the organisation.
Opportunities
Opportunities that lie in front of GSK organisation is to strategically expand their business through acquisition and collaboration. GSK collaboration will be helping them in introducing new medicines and drugs in medical science that will contribute to the welfare of society (Gsk, 2021). New product launched by GSK particularly in the metabolic and respiratory business along with introducing Nucala as a treatment for asthma in adults. GSK can also look forward to increasing the demand and consciousness about the superiority healthcare among the people that will be benefiting them in growing their trust among the customers.
Threat
The threat that is being faced by the GSK organisation includes drug pricing controls that are mainly measured by law in many countries. Furthermore, intense competition in the pharmaceutical industry such as Pfizer, Zydus Cedilla and Johnson and Johnson (Gsk, 2021). The growing competition for GSK makes it challenging for the organisation to remain competitive within the organisation making it tough for the organisation in limiting the market share. Growing government policies and new guidelines for the pharmaceutical industry makes it challenging for the firm in operating their business in the respective country.
Summarise the company performance
Examining the above SWOT analysis, it has been noticed that the strong R&D and distribution network of GSK makes it easier for the organisation in operating its business successfully. GSK also enjoys a strong global presence in different countries. The weakness of GSK includes fraud allegations that decreases the brand image of the firm. Opportunities lie in front of GSK comprise strategic expansion through collaboration and product launches. Whereas, growing competition for GSK makes it difficult for the organisation in carrying out their business successful while achieving profitability.
References
Drugwatch, 2021. Fraud, Misbranding & Failure to Report Safety Data. [Online]
Availableat:https://www.drugwatch.com/manufacturers/glaxosmithkline/#:~:text=Fraud%2C%20Misbranding%20%26%20Failure%20to%20Report,about%20its%20diabetes%20drug%20Avandia.[Accessed 14 February 2022].
Gsk,2021.Competition-antitrust.[Online] Available at: https://www.gsk.de/en/competition-antitrust/[Accessed 14 February 2022].
Gsk,2021.GSKglobally.[Online] Available at: https://www.gsk-china.com/en-gb/about-us/gskglobally/#:~:text=We%20have%20a%20significant%20global,%2C%20Spain%2C%20Belgium%20and%20China.[Accessed 14 February 2022].
Gsk,2021.Partnerships.[Online] Available at: https://www.gsk.com/en-gb/research-and-development/partnerships/[Accessed 14 February 2022].
Gsk,2021.Research-and-development.[Online] Available at: https://www.gsk.com/en-gb/research-and-development/[Accessed 14 February 2022].
________________________________________________________________________________
Know more about UniqueSubmission’s other writing services:
